Clinical Trials

Dermatomyositis

Displaying 4 studies

A Study To Evaluate The Effectiveness, Safety And Tolerability Of PF-06823859 In Adults With Moderate-to-Severe Dermatomyositis Jacksonville, FL

The purpose of this study is to evaluate the investigational drug PF-06823859 and a placebo administered to adult pPatients with moderate-to- severe Dermatomyositis.
A Phase 3 Study To Investigate The Efficacy And Safety Of Brepocitinib In Adults With Dermatomyositis Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN

The purpose of this study is to determine the effetiveness and safety of brepocitinib (a tyrosine kinase [TYK] 2/Janus kinase [JAK] 1 inhibitor) in patients with dermatomyositis.
A Study To Understand How The Study Medicine (PF-06823859) Works In People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) And Polymyositis (PM)] Scottsdale/Phoenix, AZ; Jacksonville, FL

The purpose of this study is to evaluate the effectiveness of PF-06823859 in reducing muscle symptoms in adult participants with active Dermatomyositis (DM) and adult participants with active Polymyositis (PM).
Tocilizumab In The Treatment Of Refractory Polymyositis And Dermatomyositis Rochester, MN

The purpose of this multi-center pilot study is to determine if the drug tocilizumab (Actemra) is effective in the treatment of patients with refractory adult polymyositis (PM) and dermatomyositis (DM).